Farxiga (dapagliflozin) is a prescription drug that’s used for type 2 diabetes, heart failure, kidney disease, and other conditions. Farxiga comes as an oral tablet. Farxiga (dapagliflozin) is used in ...
Type 2 diabetes is the most common form of diabetes. It can be diagnosed at any age and increases your risk of several other health problems. Farxiga (far-see-guh) is just one of the many prescription ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Both Farxiga (dapagliflozin) and Jardiance (empagliflozin) help manage blood sugar levels in adults and some children with type 2 diabetes. They also reduce risks associated with chronic kidney ...
Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The FDA has approved Farxiga (dapagliflozin) to reduce the risk of cardiovascular ...
WILMINGTON, Del.--(BUSINESS WIRE)--New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showed that AstraZeneca’s ...
Farxiga (dapagliflozin) is a prescription, brand-name medication. The Food and Drug Administration (FDA) has approved Farxiga for uses in certain adults. These uses include: Farxiga comes as an oral ...
Farxiga (dapagliflozin) is a brand-name tablet that’s prescribed for different uses in adults with type 2 diabetes, heart failure, or kidney disease. Farxiga interacts with some other drugs and ...
The U.S. Food and Drug Administration today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects ...
AstraZeneca AZN announced that the FDA granted label expansion to its blockbuster drug Farxiga (dapagliflozin) to treat pediatric patients aged 10 years and older with type-2 diabetes (T2D). Farxiga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results